new studies on glp 1 research is adding to the conversation around GLP-1 medications like Ozempic®, Wegovy®, Zepbound®, and Mounjaro®. A large study from researchers at the Cleveland Clinic found that patients taking GLP-1 medications had GLP-1 Receptor Agonist Market Growth

En conclusin, si bien parece que los incretino-mimticos pueden ser una alternativa farmacolgica para el manejo del sobrepeso y la obesidad quedan todava muchos interrogantes de su verdadera utilidad en nuestro medio

Generic programs ignore your metabolic profile Two people on the same diet can get completely different results

doi:10.3390/molecules24234262CrossRefGoogle ScholarPubMed Naviaux, RK, Curtis, B, Li, K, et al

Relation between gastric cancer and protein oxidation, DNA damage, and lipid peroxidation

In a statement to Yahoo, Eli Lilly, maker of Mounjaro and Zepbound, noted that patient safety is the company's top priority and that it actively monitors and evaluates safety information for all its medicines, encouraging anyone experiencing side effects to speak with their health care provider or contact the Lilly Answers Center at 1-800-LillyRx (1-800-545-5979)

Content reflects FY2026 ICD-10-CM guidelines (effective October 1, 2025 September 30, 2026) and incorporates current clinical practice standards from the Crohns & Colitis Foundation and the American College of Gastroenterology (ACG)